Table 2.
Cox regression analyses of overall survival (OS) in CLL patients
| Variable | Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|---|
| HR | 95% CI | p value | HR | 95% CI | p value | ||
| Binet stage | C vs A/B | 1.474 | 0.937–2.389 | 0.105 | |||
| CTPS2 expression | High vs low | 2.745 | 2.018–3.734 | 0.001*** | 0.666 | 0.416–1.064 | 0.049* |
| β2-MG (mg/ L) | < 3 vs ≥ 3 | 0.021 | 0.003–0.126 | 0.001*** | 0.001 | 0.001–0.538 | 0.876 |
| IGHV status | Unmutated vs mutated | 2.923 | 0.000–87.321 | 0.844 | |||
| CD38 | Positive vs negative | 5.279 | 0.735–37.927 | 0.098 | |||
| ZAP70 | Positive vs negative | 21.715 | 0.109–36.449 | 0.254 | |||
Bold font indicates statistical significance
WBC White blood cell; LDH Lactate dehydrogenase; β2-MG β2-microglobulin; HR Hazard ratio; CI Confidence interval
*p < 0.05
***p < 0.001